Skip to main content

Table 1 Patients’ characteristics and operative data

From: Effect of perioperative magnesium sulfate and labetalol infusion on peripheral perfusion and postoperative pain in nasal surgery: a randomized controlled trial

 

Studied groups

t/x2

p-value

Magnesium sulfate group

(n = 25)

Labetalol group

(n = 25)

Age(years)

31.8 ± 5.6

32.9 ± 5.7

t = 0.67

0.50

Sex

  male

14 (56%)

13 (52%)

x2 = 0.08

0.77

  female

11 (44%)

12 (48%)

ASA

I

13 (52%)

14 (56%)

x2 = 0.08

0.77

II

12 (48%)

11 (44%)

BMI (kg/m2)

25.5 ± 2.6

25.2 ± 2.7

t = 0 .35

0.72

Duration of surgery ( min)

104.2 ± 7.1

104.1 ± 5.5

t = 0.09

0.93

Type of surgery

  • Endoscopic septoplasty

4 (16%)

5 (20%)

x2 = 0.36

1

  • FESS

10(40%)

1144%)

  • Rhinoplasty

6 (24%)

a.(20%)

  • Septoturbanoplasty

5 (20%)

4 (16%)

  1. Data were expressed as mean ± SD, or No (%). P < 0.05 was significant. t = unpaired t- test. x2 = chi square test. ASA American Society of Anesthesiologist, BMI Body Mass Index and FESS Functional Endoscopic Sinus Surgery